Giacomo Sgalla

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 24

Top Topics

Idiopathic Pulmonary Fibrosis

Rheumatoid Arthritis Patients

Top Venues

Expert opinion on investigational drugs

American journal of respiratory and critical care medicine

BMC pulmonary medicine

Respirology (Carlton, Vic.)

This page only lists publications with an associated author ORCID identifier.

Publications

Giacomo Sgalla, Elena Bargagli
Hospitalizations as Clinical Trials Endpoint in ILD: Are We There Yet? American journal of respiratory and critical care medicine (2024)
Giacomo Sgalla, Jacopo Simonetti, Stefania Cortese, Luca Richeldi
BI 1015550: an investigational phosphodiesterase 4B (PDE4B) inhibitor for lung function decline in idiopathic pulmonary fibrosis (IPF). Expert opinion on investigational drugs 32 (1) (2023)
Francesca Gobbo, Maria Zingariello, Paola Verachi, Mario Falchi, Francesca Arciprete, Fabrizio Martelli, Angelo Peli, Maria Mazzarini, Jeff Vierstra, Carolyn Mead-Harvey, Amylou C Dueck, Giuseppe Sarli, Stefano Nava, Giacomo Sgalla, Luca Richeldi, Anna Rita Migliaccio
GATA1-defective immune-megakaryocytes as possible drivers of idiopathic pulmonary fibrosis. bioRxiv : the preprint server for biology (2023)
Giacomo Sgalla, Jacopo Simonetti, Stefania Cortese, Luca Richeldi
BI 1015550: an investigational phosphodiesterase 4B (PDE4B) inhibitor for lung function decline in idiopathic pulmonary fibrosis (IPF). Expert opinion on investigational drugs (2023)
Giacomo Sgalla, Jacopo Simonetti, Stefania Cortese, Luca Richeldi
BI 1015550: an investigational phosphodiesterase 4B (PDE4B) inhibitor for lung function decline in idiopathic pulmonary fibrosis (IPF). Expert opinion on investigational drugs 32 (1) (2023)
Giacomo Sgalla, Jacopo Simonetti, Stefania Cortese, Luca Richeldi
BI 1015550: an investigational phosphodiesterase 4B (PDE4B) inhibitor for lung function decline in idiopathic pulmonary fibrosis (IPF). Expert opinion on investigational drugs 32 (1) (2023)
Giacomo Sgalla, Paolo Maria Leone, Gina Gualano, Jacopo Simonetti, Alessia Comes, Diana Verdirosi, Francesco Di Gennaro, Anna Rita Larici, Stefania Ianniello, Giuseppe Cicchetti, Nicoletta Fusco, Marcello Pani, Fabrizio Palmieri, Luca Richeldi
A randomized trial of pamrevlumab in patients with COVID-19 pneumonia. Respirology (Carlton, Vic.) (2023)
Giacomo Sgalla, Jacopo Simonetti, Stefania Cortese, Luca Richeldi
BI 1015550: an investigational phosphodiesterase 4B (PDE4B) inhibitor for lung function decline in idiopathic pulmonary fibrosis (IPF). Expert opinion on investigational drugs (2023)
Giacomo Sgalla, Luca Richeldi
Better be an Agnostic than a Believer (at Least in Pulmonary Fibrosis). American journal of respiratory and critical care medicine (2022)
Giacomo Sgalla, Tonia Magrì, Marialessia Lerede, Alessia Comes, Luca Richeldi
COVID-19 Vaccine in Patients with Exacerbation of Idiopathic Pulmonary Fibrosis. American journal of respiratory and critical care medicine 206 (2) (2022)
Giacomo Sgalla, Luca Richeldi
Reply to Huang and Wei, Kang et al ., and Ehteshami-Afshar and Raj. American journal of respiratory and critical care medicine 206 (7) (2022)
Giacomo Sgalla, Bruno Iovene, Teresa Bruni, Maria Chiara Flore, Lucia Maria Porro, Ajit Lalvani, Luca Richeldi
Telemedicine-enabled, Hotel-based Management of Patients with COVID-19: A Single-Center Feasibility Study. Annals of the American Thoracic Society 18 (10) (2021)
Giacomo Sgalla, Alessia Comes, Marialessia Lerede, Luca Richeldi
COVID-related fibrosis: insights into potential drug targets. Expert opinion on investigational drugs (2021)
Giacomo Sgalla, Marialessia Lerede, Luca Richeldi
Emerging drugs for the treatment of idiopathic pulmonary fibrosis: 2020 phase II clinical trials. Expert opinion on emerging drugs 26 (2) (2021)
Alessia Comes, Giacomo Sgalla, Alessandro Perrotta, Luca Richeldi
Advances with pharmacotherapy for the treatment of interstitial lung disease. Expert opinion on pharmacotherapy 23 (4) (2021)
Giacomo Sgalla, Alessia Comes, Luca Richeldi
An updated safety review of the drug treatments for idiopathic pulmonary fibrosis. Expert opinion on drug safety 20 (9) (2021)
Giacomo Sgalla, Mariachiara Flore, Matteo Siciliano, Luca Richeldi
Antibody-based therapies for idiopathic pulmonary fibrosis. Expert opinion on biological therapy 20 (7) (2020)
Giacomo Sgalla, Anna Rita Larici, Nicoletta Golfi, Mariarosaria Calvello, Alessandra Farchione, Annemilia Del Ciello, Francesco Varone, Bruno Iovene, Riccardo Manfredi, Luca Richeldi
Mediastinal lymph node enlargement in idiopathic pulmonary fibrosis: relationships with disease progression and pulmonary function trends. BMC pulmonary medicine 20 (1) (2020)
Giacomo Sgalla, Erminia Lo Greco, Mariarosaria Calvello, Francesco Varone, Bruno Iovene, Stefania Cerri, Pierluigi Donatelli, Ada Vancheri, Mauro Pavone, Fabrizio Luppi, Carlo Vancheri, Luca Richeldi
Disease progression across the spectrum of idiopathic pulmonary fibrosis: A multicentre study. Respirology (Carlton, Vic.) 25 (11) (2020)
Giacomo Sgalla, Claudia Franciosa, Jacopo Simonetti, Luca Richeldi
Pamrevlumab for the treatment of idiopathic pulmonary fibrosis. Expert opinion on investigational drugs 29 (8) (2020)
Luca Richeldi, Vincent Cottin, Gebhard Würtemberger, Michael Kreuter, Mariarosaria Calvello, Giacomo Sgalla
Digital Lung Auscultation: Will Early Diagnosis of Fibrotic Interstitial Lung Disease Become a Reality? American journal of respiratory and critical care medicine 200 (2) (2020)
Giacomo Sgalla, Anna Rita Larici, Antonina Re, Alessandra Farchione, Giuseppe Cicchetti, Lucio Calandriello, Alessia Comes, Nicoletta Golfi, Bruno Iovene, Francesco Varone, Riccardo Manfredi, Luca Richeldi
Impact of chest imaging quality on the diagnosis of the usual interstitial pneumonia pattern: a hub and spoke study. The European respiratory journal 53 (6) (2019)
Giacomo Sgalla, Bruno Iovene, Mariarosaria Calvello, Margherita Ori, Francesco Varone, Luca Richeldi
Idiopathic pulmonary fibrosis: pathogenesis and management. Respiratory research 19 (1) (2018)
Giacomo Sgalla, Simon L F Walsh, Nicola Sverzellati, Sophie Fletcher, Stefania Cerri, Borislav Dimitrov, Dragana Nikolic, Anna Barney, Fabrizio Pancaldi, Luca Larcher, Fabrizio Luppi, Mark G Jones, Donna Davies, Luca Richeldi
"Velcro-type" crackles predict specific radiologic features of fibrotic interstitial lung disease. BMC pulmonary medicine 18 (1) (2018)